首页> 外文期刊>European journal of endocrinology >The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto’s thyroiditis
【24h】

The impact of levothyroxine sodium treatment on oxidative stress in Hashimoto’s thyroiditis

机译:左甲状腺素钠治疗对桥本甲状腺炎的氧化应激的影响

获取原文
           

摘要

Objective Although several studies reported increased oxidative stress in Hashimoto’s thyroiditis (HT), the effect of levothyroxine treatment on oxidative status is not studied extensively. Therefore, we conducted this study to investigate the effects of levothyroxine replacement on oxidative stress in HT. Design and methods Thirty-six patients recently diagnosed with HT-related hypothyroidism and 36 healthy controls were included in the study. Levothyroxine replacement was started to patients with hypothyroidism, and had been followed-up for 6 months. Results Mean basal serum total antioxidant status (TAS), total thiol, arylesterase, and paraoxonase 1 (PON1) levels were significantly lower, and serum total oxidant status (TOS) and oxidative stress index (OSI) were significantly higher in the patients with hypothyroid than the controls. In the hypothyroid group serum TAS, total thiol, arylesterase, and PON1 levels increased and serum TOS and OSI levels decreased significantly after levothyroxine treatment. Pretreatment serum TAS, total thiol, PON1, and arylesterase levels were positively correlated with free levothyroxine (fT _( 4 ) ) and negatively correlated with thyroid-stimulating hormone (TSH), antithyroid peroxidase (anti-TPO), and antithyroglobulin (anti-TG) levels. Also, pretreatment serum TOS and OSI levels were negatively correlated with fT _( 4 ) levels and positively correlated with TSH, anti-TPO, and anti-TG. We have also found that the fT _( 4 ) and anti-TPO levels are independent predictors of the oxidative stress parameters in stepwise multivariable linear regression analysis. Conclusion This study suggests that levothyroxine replacement decreases oxidant status and increases antioxidant status following the 6 months of levothyroxine replacement in hypothyroidism that develops in accordance with the HT.
机译:目的尽管有几项研究报道了桥本甲状腺炎(HT)中氧化应激的增加,但尚未广泛研究左甲状腺素治疗对氧化状态的影响。因此,我们进行了这项研究,以调查左甲状腺素替代对HT氧化应激的影响。设计与方法本研究纳入了36名最近被诊断为HT相关性甲状腺功能低下的患者和36名健康对照。甲状腺功能减退患者开始使用左甲状腺素替代治疗,并随访了6个月。结果甲状腺功能减退患者的平均基础血清总抗氧化剂状态(TAS),总硫醇,芳基酯酶和对氧磷酶1(PON1)水平显着降低,血清总氧化剂状态(TOS)和氧化应激指数(OSI)显着升高比控件。甲状腺功能减退组的左甲状腺素治疗后,总血清TAS,总硫醇,芳基酯酶和PON1水平升高,血清TOS和OSI水平显着下降。预处理的血清TAS,总硫醇,PON1和芳基酯酶水平与游离左甲状腺素(fT _(4))正相关,与促甲状腺激素(TSH),抗甲状腺过氧化物酶(anti-TPO)和抗甲状腺球蛋白(anti-thoroglobulin)呈负相关。 TG)水平。同样,预处理血清TOS和OSI水平与fT_(4)水平呈负相关,与TSH,抗TPO和抗TG正相关。我们还发现,在逐步多变量线性回归分析中,fT_(4)和抗TPO水平是氧化应激参数的独立预测因子。结论这项研究表明,在根据HT发生的甲状腺功能减退症中,在6个月内更换甲状腺素后,左甲状腺素替代可降低氧化剂状态并增加抗氧化剂状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号